KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
300138 Chenguang Biotech Group
- 9.28
- -0.30-3.13%
Market Closed Dec 13 15:00 CST
4.48BMarket Cap31.14P/E (TTM)
9.58High9.24Low127.65KlotVolume9.58Open9.58Pre Close119.81MTurnover3.21%Turnover Ratio9.35P/E (Static)483.10MShares13.3752wk High1.74P/B3.70BFloat Cap6.9152wk Low11.50Limit Up398.31MShs Float21.28Historical High7.66Limit Down3.55%Amplitude2.38Historical Low0.13Dividend TTM9.39Avg Price79.66KlotAsk1.40%Div YieldTTM100Lot Size45.21KlotBid
Chenguang Biotech Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 1.08%5.23B | -4.85%3.49B | -4.71%1.73B | 9.14%6.87B | 7.78%5.17B | 13.68%3.67B | 14.71%1.82B | 29.18%6.3B | 49.65%4.8B | 53.74%3.23B |
| Operating revenue | 1.08%5.23B | -4.85%3.49B | -4.71%1.73B | 9.14%6.87B | 7.78%5.17B | 13.68%3.67B | 14.71%1.82B | 29.18%6.3B | 49.65%4.8B | 53.74%3.23B |
| Other operating revenue | ---- | -23.61%547.16M | ---- | -1.77%1.2B | ---- | 41.05%716.24M | ---- | 32.27%1.22B | ---- | 133.96%507.79M |
| Total operating cost | 6.80%5.13B | 0.04%3.41B | -0.04%1.69B | 10.49%6.45B | 7.73%4.8B | 13.34%3.41B | 14.81%1.69B | 29.01%5.84B | 50.12%4.46B | 55.13%3.01B |
| Operating cost | 6.67%4.84B | -1.09%3.2B | 0.26%1.59B | 12.10%6.07B | 9.50%4.54B | 15.79%3.24B | 15.80%1.59B | 30.42%5.42B | 52.12%4.14B | 56.58%2.8B |
| Operating tax surcharges | 10.89%13.34M | 6.33%8.8M | 4.04%3.89M | -0.28%16.77M | -5.62%12.03M | 0.39%8.28M | -9.17%3.74M | 23.11%16.82M | 46.40%12.75M | 29.37%8.25M |
| Operating expense | -26.61%33.69M | -11.89%26.07M | 21.64%13.68M | 3.55%61.08M | 8.06%45.9M | 18.70%29.58M | 5.97%11.24M | 7.12%58.98M | 21.96%42.48M | 10.21%24.92M |
| Administration expense | -1.81%113.59M | 3.60%79.59M | -16.46%34.63M | -19.83%154.61M | -18.80%115.68M | -20.09%76.82M | -14.23%41.46M | 22.92%192.86M | 32.79%142.47M | 50.14%96.13M |
| Financial expense | 90.60%53.93M | 162.10%44.25M | -21.70%21.57M | 108.22%47.35M | 71.33%28.29M | -36.43%16.88M | 37.90%27.55M | -55.22%22.74M | -54.19%16.51M | 0.78%26.56M |
| -Interest expense (Financial expense) | 37.55%83.83M | 54.63%65.14M | 31.58%31.75M | 24.25%83.51M | 0.00%60.95M | -9.60%42.13M | 7.12%24.13M | 26.46%67.21M | 48.80%60.95M | 58.29%46.6M |
| -Interest Income (Financial expense) | -19.95%-32.03M | -24.42%-19.05M | -64.13%-9.92M | -43.70%-35.63M | -121.46%-26.7M | -217.33%-15.31M | -144.68%-6.05M | -169.37%-24.8M | -64.25%-12.06M | 6.19%-4.82M |
| Research and development | 18.53%72.44M | 24.78%47.91M | 29.94%23.15M | -24.51%97.4M | -37.75%61.11M | -29.43%38.4M | 2.19%17.81M | 36.11%129.03M | 70.56%98.17M | 65.57%54.42M |
| Credit Impairment Loss | 6.74%-312.06K | -29.38%-700.64K | -190.24%-154.73K | -47.21%-1.13M | 46.68%-334.6K | -51.94%-541.52K | 90.22%171.45K | -139.59%-765.18K | -487.34%-627.56K | -388.53%-356.41K |
| Asset Impairment Loss | -767.59%-82.67M | -118.36%-2.37M | -418.88%-2.43M | 112.99%4.06M | 347.58%12.38M | 311.27%12.91M | 115.65%762.07K | -20.32%-31.22M | -491.09%-5M | -443.17%-6.11M |
| Other net revenue | -139.75%-38.1M | -72.53%25.33M | -103.81%-925.65K | 329.50%127.62M | 162.75%95.87M | 132.76%92.22M | 987.41%24.3M | -19.65%29.71M | -22.10%36.49M | -9.84%39.62M |
| Fair value change income | 142.31%1.12M | -197.94%-6.45M | -831.66%-38.87M | 206.75%5.36M | 64.78%-2.65M | 2,231.04%6.58M | 1,608.62%5.31M | -990.85%-5.02M | ---7.52M | 185.23%282.42K |
| Invest income | -86.43%7.27M | -66.44%15.99M | 209.28%32.77M | 78.43%68.65M | 59.88%53.59M | 51.41%47.64M | 628.05%10.6M | 26.69%38.48M | 23.57%33.52M | 25.03%31.47M |
| -Including: Investment income associates | -0.35%10.02M | 2.28%11.39M | 364.67%10.81M | -35.48%13.12M | -52.77%10.05M | -55.65%11.14M | 485.19%2.33M | 13.26%20.34M | 18.73%21.28M | 25.79%25.11M |
| Asset deal income | ---- | ---- | ---- | -158.73%-632.75K | -99.97%189.31 | -100.46%-1.55K | 72.57%29.64K | 1,003.84%1.08M | 786.93%716.92K | 273.69%335.41K |
| Other revenue | 10.98%36.49M | -26.40%18.86M | 4.36%7.75M | 88.82%51.31M | 113.41%32.88M | 83.01%25.63M | 26.08%7.43M | -9.32%27.17M | -15.31%15.41M | -18.19%14M |
| Operating profit | -87.04%60.26M | -69.54%107.81M | -71.28%44.34M | 12.59%548.32M | 23.37%464.83M | 35.64%353.98M | 31.98%154.39M | 26.54%487.01M | 32.89%376.77M | 27.05%260.97M |
| Add:Non operating Income | 108.98%17.38M | 70.21%6.93M | -70.82%458.28K | -43.40%9.91M | -24.76%8.32M | -45.44%4.07M | -36.63%1.57M | -14.23%17.5M | -7.45%11.05M | -19.39%7.46M |
| Less:Non operating expense | 65.00%3.29M | -55.75%648.78K | 33.74%549.54K | -12.43%2.41M | 30.52%1.99M | 28.80%1.47M | -36.15%410.91K | -61.79%2.75M | -61.22%1.53M | -34.28%1.14M |
| Total profit | -84.22%74.35M | -68.00%114.09M | -71.55%44.25M | 10.77%555.82M | 21.97%471.15M | 33.40%356.58M | 30.91%155.55M | 26.05%501.76M | 32.51%386.29M | 25.53%267.29M |
| Less:Income tax cost | -47.10%29.11M | -51.30%20.3M | -27.87%11.26M | -6.13%61.65M | 15.15%55.04M | 54.84%41.69M | 30.62%15.61M | 38.35%65.67M | 46.72%47.8M | 9.11%26.92M |
| Net profit | -89.13%45.24M | -70.22%93.79M | -76.42%32.99M | 13.32%494.17M | 22.93%416.11M | 31.00%314.89M | 30.95%139.94M | 24.38%436.09M | 30.72%338.5M | 27.68%240.37M |
| Net profit from continuing operation | -89.13%45.24M | -70.22%93.79M | -76.42%32.99M | 13.32%494.17M | 22.93%416.11M | 31.00%314.89M | 30.95%139.94M | 24.38%436.09M | 30.72%338.5M | 27.68%240.37M |
| Less:Minority Profit | -197.80%-17.37M | -137.22%-6.04M | -214.27%-5.6M | 604.27%14.45M | 921.95%17.76M | 58,612.96%16.24M | 8,875.27%4.9M | 324.08%2.05M | 360.94%1.74M | 93.65%-27.75K |
| Net profit of parent company owners | -84.28%62.61M | -66.57%99.83M | -71.42%38.59M | 10.53%479.72M | 18.29%398.36M | 24.23%298.65M | 26.30%135.04M | 23.48%434.03M | 29.72%336.76M | 27.40%240.4M |
| Earning per share | ||||||||||
| Basic earning per share | -84.00%0.12 | -66.07%0.19 | -71.40%0.0725 | 10.68%0.9017 | 19.05%0.75 | 24.44%0.56 | 26.31%0.2535 | 22.49%0.8147 | 28.57%0.63 | 18.42%0.45 |
| Diluted earning per share | -84.00%0.12 | -66.07%0.19 | -71.40%0.0725 | 10.68%0.9017 | 19.05%0.75 | 24.44%0.56 | 26.31%0.2535 | 22.49%0.8147 | 28.57%0.63 | 18.42%0.45 |
| Other composite income | -148.48%-6.51M | -85.52%2.76M | -94.63%567.01K | -49.94%7.22M | -55.26%13.42M | 63.64%19.05M | 340.37%10.56M | 244.60%14.43M | 893.36%30M | 328.91%11.64M |
| Other composite income of parent company owners | -148.48%-6.51M | -85.52%2.76M | -94.63%567.01K | -49.94%7.22M | -55.26%13.42M | 63.64%19.05M | 340.37%10.56M | 244.60%14.43M | 893.36%30M | 328.91%11.64M |
| Total composite income | -90.98%38.73M | -71.09%96.55M | -77.70%33.56M | 11.29%501.4M | 16.56%429.53M | 32.51%333.94M | 46.86%150.5M | 32.26%450.51M | 44.42%368.5M | 37.58%252.01M |
| Total composite income of parent company owners | -86.38%56.1M | -67.71%102.59M | -73.11%39.16M | 8.58%486.95M | 12.27%411.78M | 26.05%317.7M | 42.01%145.6M | 31.31%448.46M | 43.36%366.76M | 37.27%252.04M |
| Total composite income of minority owners | -197.80%-17.37M | -137.22%-6.04M | -214.27%-5.6M | 604.27%14.45M | 921.95%17.76M | 58,612.96%16.24M | 8,875.27%4.9M | 324.08%2.05M | 360.94%1.74M | 93.65%-27.75K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
